Floatz logo

Metformin

Gonadal Dysfunction

University of Colorado, DenverSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gonadal Dysfunction cohort.

Asset / SponsorPhaseRating
Niraparib
Xiaoxiang Chen
Phase 2CCC
CLOMIPHENE CITRATE
Royan Institute
Phase 1/2CCC
Hcg
Royan Institute
Phase 1/2CCC
MENOTROPHIN
Royan Institute
Phase 1/2CCC

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →